BRD4 and head and neck squamous cell carcinoma: To further explore the importance of BRD4 in HPV-positive HNSCC, a BRD4 inhibitor, MZ1, was used; this inhibitor is a proteolysis targeting chimera (PROTAC) which causes degradation of the target protein [45].